Haurwitz Rachel E.
Insider CIK 1670579 · CRBU President and CEO, Director · NTLA Director, 10% owner · SEER Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2026-02-20 | 2026-02-20 | 682,500 | — | $0 | 682,500 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award | 2026-02-20 | 2026-02-20 | 151,700 | — | $0 | 447,150 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | P Buy | 2025-03-14 | 2025-03-17 | 20,000 | $1.02 | $20.4K | 3,369,395 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2025-02-20 | 2025-02-21 | 618,250 | — | $0 | 618,250 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award | 2025-02-20 | 2025-02-21 | 136,750 | — | $0 | 295,450 | SEC↗ |
| SEER Seer, Inc. | A Award | 2024-06-12 | 2024-06-14 | 58,178 | — | $0 | 87,615 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2024-02-20 | 2024-02-22 | 546,950 | — | $0 | 546,950 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award | 2024-02-20 | 2024-02-22 | 118,700 | — | $0 | 158,700 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 34,735 | — | $0 | 34,735 | SEC↗ |
| SEER Seer, Inc. | A Award | 2023-06-14 | 2023-06-16 | 23,443 | — | $0 | 29,437 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | M Exercise deriv | 2023-06-08 | 2023-06-09 | 10,000 | — | $0 | 96,350 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | M Exercise | 2023-06-08 | 2023-06-09 | 10,000 | $2.96 | $29.6K | 40,000 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | M Exercise deriv | 2023-03-20 | 2023-03-22 | 10,000 | — | $0 | 106,350 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | M Exercise | 2023-03-20 | 2023-03-22 | 10,000 | $2.96 | $29.6K | 30,000 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2023-02-21 | 2023-02-23 | 510,500 | — | $0 | 510,500 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 17,865 | — | $0 | 17,865 | SEC↗ |
| SEER Seer, Inc. | A Award | 2022-06-15 | 2022-06-17 | 5,994 | — | $0 | 5,994 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | M Exercise deriv | 2022-05-09 | 2022-05-10 | 10,000 | — | $0 | 116,350 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | M Exercise | 2022-05-09 | 2022-05-10 | 10,000 | $2.96 | $29.6K | 20,000 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | M Exercise deriv | 2022-01-26 | 2022-05-10 | 10,000 | — | $0 | 126,350 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | M Exercise | 2022-01-26 | 2022-05-10 | 10,000 | $2.96 | $29.6K | 10,000 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | M Exercise deriv | 2022-01-26 | 2022-01-27 | 10,000 | — | $0 | 126,350 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | M Exercise | 2022-01-26 | 2022-01-27 | 10,000 | $2.96 | $29.6K | 3,359,395 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2021-12-20 | 2021-12-21 | 411,000 | — | $0 | 411,000 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2021-11-09 | 2021-11-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-11 | 270,352 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-11 | 8,110,599 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-11 | 5,244,234 | — | $0 | 5,593,846 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-11 | 174,806 | — | $0 | 349,612 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2016-05-05 | 2016-05-09 | 23,529 | — | $0 | 23,529 | SEC↗ |